These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18339112)

  • 41. Fewer emergency readmissions and better quality of life for older adults at risk of hospital readmission: a randomized controlled trial to determine the effectiveness of a 24-week exercise and telephone follow-up program.
    Courtney M; Edwards H; Chang A; Parker A; Finlayson K; Hamilton K
    J Am Geriatr Soc; 2009 Mar; 57(3):395-402. PubMed ID: 19245413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness of targeted and tailored interventions on colorectal cancer screening use.
    Lairson DR; DiCarlo M; Myers RE; Wolf T; Cocroft J; Sifri R; Rosenthal M; Vernon SW; Wender R
    Cancer; 2008 Feb; 112(4):779-88. PubMed ID: 18098272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A multiprofessional education programme for patients with inflammatory bowel disease: a randomized controlled trial.
    Jäghult S; Larson J; Wredling R; Kapraali M
    Scand J Gastroenterol; 2007 Dec; 42(12):1452-9. PubMed ID: 17852871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The headache management trial: a randomized study of coordinated care.
    Matchar DB; Harpole L; Samsa GP; Jurgelski A; Lipton RB; Silberstein SD; Young W; Kori S; Blumenfeld A
    Headache; 2008 Oct; 48(9):1294-310. PubMed ID: 18547268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discontinuation of long-term benzodiazepine use: 10-year follow-up.
    de Gier NA; Gorgels WJ; Lucassen PL; Oude Voshaar R; Mulder J; Zitman F
    Fam Pract; 2011 Jun; 28(3):253-9. PubMed ID: 21193495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of minimal contact education strategies for cholesterol change.
    Gans KM; Burkholder GJ; Risica PM; Harrow B; Lasater TM
    Ethn Dis; 2006; 16(2):443-51. PubMed ID: 17682247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial.
    Lennox AS; Osman LM; Reiter E; Robertson R; Friend J; McCann I; Skatun D; Donnan PT
    BMJ; 2001 Jun; 322(7299):1396. PubMed ID: 11397745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment methods for discontinuation of long-term benzodiazepine use].
    Oude Voshaar RC; Gorgels WJ; Mol AJ; Couvée JE; van Balkom AJ; Zitman FG
    Ned Tijdschr Geneeskd; 2001 Jul; 145(28):1347-50. PubMed ID: 11484431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brief intervention in general hospital for problematic prescription drug use: 12-month outcome.
    Otto C; Crackau B; Löhrmann I; Zahradnik A; Bischof G; John U; Rumpf HJ
    Drug Alcohol Depend; 2009 Dec; 105(3):221-6. PubMed ID: 19726140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Consequences of a benzodiazepine discontinuation programme in family practice on psychotropic medication prescription to the participants.
    Gorgels WJ; Oude Voshaar RC; Mol AJ; van de Lisdonk EH; Mulder J; van den Hoogen H; van Balkom AJ; Breteler MH; Zitman FG
    Fam Pract; 2007 Oct; 24(5):504-10. PubMed ID: 17644828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial.
    Tannenbaum C; Martin P; Tamblyn R; Benedetti A; Ahmed S
    JAMA Intern Med; 2014 Jun; 174(6):890-8. PubMed ID: 24733354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A letter to benzodiazepine users--an efficient way to reduce the prescription].
    Mouland G
    Tidsskr Nor Laegeforen; 1997 Sep; 117(21):3097-100. PubMed ID: 9381445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Usefulness of a run-in period to reduce drop-outs in a randomized controlled trial of a behavioral intervention.
    Ulmer M; Robinaugh D; Friedberg JP; Lipsitz SR; Natarajan S
    Contemp Clin Trials; 2008 Sep; 29(5):705-10. PubMed ID: 18565801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tailoring advice and optimizing response: a case study of a telephone-based support for patients with type 2 diabetes.
    Gambling T; Long A
    Fam Pract; 2010 Apr; 27(2):179-85. PubMed ID: 20032169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods.
    McGregor C; Machin A; White JM
    Drug Alcohol Rev; 2003 Jun; 22(2):175-80. PubMed ID: 12850904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short- and long-term effects of tailored information versus general information on determinants and intentions related to early detection of cancer.
    de Nooijer J; Lechner L; Candel M; de Vries H
    Prev Med; 2004 Jun; 38(6):694-703. PubMed ID: 15193889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. First benzodiazepine prescriptions: qualitative study of patients' perspectives.
    Anthierens S; Habraken H; Petrovic M; Deveugele M; De Maeseneer J; Christiaens T
    Can Fam Physician; 2007 Jul; 53(7):1200-1. PubMed ID: 17872818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospective cohort study into post-disaster benzodiazepine use demonstrated only short-term increase.
    Dorn T; Yzermans CJ; van der Zee J
    J Clin Epidemiol; 2007 Aug; 60(8):795-802. PubMed ID: 17606175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term benzodiazepine users--characteristics, views and effectiveness of benzodiazepine reduction information leaflet.
    Chung KF; Cheung RC; Tam JW
    Singapore Med J; 1999 Mar; 40(3):138-43. PubMed ID: 10402890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An intervention to improve benzodiazepine use--a new approach.
    Smith AJ; Tett SE
    Fam Pract; 2010 Jun; 27(3):320-7. PubMed ID: 20237108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.